Managing The GLP-1 Surge: Creating a Framework for Cardiometabolic Health

As GLP-1 utilization continues to rise, employers face increasing pressure to balance access, outcomes, and affordability. While much of the conversation focuses on medication costs, long-term success depends on effective clinical oversight, behavioral support, and coordinated care. Our new white paper, Managing the GLP-1 Surge: Creating a Framework for Cardiometabolic Health, explores how employers can improve outcomes, support sustainable behavior change, and better manage the financial impact of GLP-1 therapies. Download the white paper now to learn more.